Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2015 (2015), Article ID 313740, 11 pages
http://dx.doi.org/10.1155/2015/313740
Research Article

Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules

1Center for Kidney Disease, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, China
2Department of Urinary Surgery, Qianfoshan Hospital Affiliated to Shandong University, 16766 Jingshi Road, Jinan, Shandong 250014, China

Received 18 June 2015; Revised 31 July 2015; Accepted 11 August 2015

Academic Editor: Konstantin Blyuss

Copyright © 2015 Shao-Mei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. An, Y. Zhu, L. Xu, L. Chen, Z. Lin, and J. Xu, “Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection,” Urology, vol. 85, no. 2, pp. 483.e9–483.e14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Vincenzo, G. Novara, A. Galfano et al., “The ‘stage, size, grade and necrosis’ score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma,” BJU International, vol. 103, no. 2, pp. 165–170, 2009. View at Publisher · View at Google Scholar
  3. V. R. Dondeti, B. Wubbenhorst, P. Lal et al., “Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets,” Cancer Research, vol. 72, no. 1, pp. 112–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. H. Girgis, V. V. Iakovlev, B. Beheshti et al., “Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma,” Cancer Research, vol. 72, no. 20, pp. 5273–5284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. W. Marston, T. A. Rouault, J. Mitchell, and M. K. Cherukuri, “Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC),” Google Patents, 2014.
  6. T. Tanaka, T. Torigoe, Y. Hirohashi et al., “Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 140, no. 3, pp. 503–513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Jordán, T.-P. Nguyen, and W.-C. Liu, “Studying protein-protein interaction networks: a systems view on diseases,” Briefings in Functional Genomics, vol. 11, no. 6, pp. 497–504, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Srihari and H. W. Leong, “Temporal dynamics of protein complexes in PPI networks: a case study using yeast cell cycle dynamics,” BMC Bioinformatics, vol. 13, article S16, 2012. View at Google Scholar · View at Scopus
  9. J. Zhao, S. Zhang, L.-Y. Wu, and X.-S. Zhang, “Efficient methods for identifying mutated driver pathways in cancer,” Bioinformatics, vol. 28, no. 22, pp. 2940–2947, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Srihari, C. H. Yong, A. Patil, and L. Wong, “Methods for protein complex prediction and their contributions towards understanding the organisation, function and dynamics of complexes,” FEBS Letters, 2015. View at Publisher · View at Google Scholar
  11. C. Wu, J. Zhu, and X. Zhang, “Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes,” BMC Bioinformatics, vol. 13, article 182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Liu, J. Li, and L. Wong, “Assessing and predicting protein interactions using both local and global network topological metrics,” Genome Informatics, vol. 21, pp. 138–149, 2008. View at Google Scholar · View at Scopus
  13. L.-H. Chu and B.-S. Chen, “Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets,” BMC Systems Biology, vol. 2, article 56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Magger, Y. Y. Waldman, E. Ruppin, and R. Sharan, “Enhancing the prioritization of disease-causing genes through tissue specific protein interaction networks,” PLoS Computational Biology, vol. 8, no. 9, Article ID e1002690, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Srihari and M. A. Ragan, “Systematic tracking of dysregulated modules identifies novel genes in cancer,” Bioinformatics, vol. 29, no. 12, pp. 1553–1561, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Szklarczyk, A. Franceschini, M. Kuhn et al., “The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored,” Nucleic Acids Research, vol. 39, no. 1, pp. D561–D568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Irizarry, B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs, and T. P. Speed, “Summaries of Affymetrix GeneChip probe level data,” Nucleic Acids Research, vol. 31, no. 4, article e15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Bolstad, R. A. Irizarry, M. Åstrand, and T. P. Speed, “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias,” Bioinformatics, vol. 19, no. 2, pp. 185–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Ben, affy: Built-in Processing Methods, 2013.
  20. N. Gerhard, “Pearson correlation coefficient,” in Dictionary of Pharmaceutical Medicine, p. 132, Springer, 2009. View at Google Scholar
  21. G. Liu, L. Wong, and H. N. Chua, “Complex discovery from weighted PPI networks,” Bioinformatics, vol. 25, no. 15, pp. 1891–1897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Srihari and H. W. Leong, “A survey of computational methods for protein complex prediction from protein interaction networks,” Journal of Bioinformatics and Computational Biology, vol. 11, no. 2, Article ID 1230002, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Tomita, A. Tanaka, and H. Takahashi, “The worst-case time complexity for generating all maximal cliques and computational experiments,” Theoretical Computer Science, vol. 363, no. 1, pp. 28–42, 2006. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet · View at Scopus
  24. H. N. Gabow, “An efficient implementation of Edmonds' algorithm for maximum matching on graphs,” Journal of the ACM, vol. 23, no. 2, pp. 221–234, 1976. View at Publisher · View at Google Scholar · View at MathSciNet
  25. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Ford, Z. Xu, A. Gates, J. Jiang, and B. D. Ford, “Expression Analysis Systematic Explorer (EASE) analysis reveals differential gene expression in permanent and transient focal stroke rat models,” Brain Research, vol. 1071, no. 1, pp. 226–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Siljamäki, L. Raiko, M. Toriseva et al., “P38δ mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes,” Archives of Dermatological Research, vol. 306, no. 2, pp. 131–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. P. J. Roberts and C. J. Der, “Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer,” Oncogene, vol. 26, no. 22, pp. 3291–3310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. I. M. Subbiah, G. Varadhachary, A. M. Tsimberidou et al., “Abstract 4700: One size does not fit all: Fingerprinting advanced carcinoma of unknown primary through comprehensive profiling identifies aberrant activation of the PI3K and MAPK signaling cascades in concert with impaired cell cycle arrest,” Cancer Research, vol. 74, no. 19, article 4700, 2014. View at Publisher · View at Google Scholar
  30. B. H. O'Neil, L. W. Goff, J. S. W. Kauh et al., “Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma,” Journal of Clinical Oncology, vol. 29, no. 17, pp. 2350–2356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Cribier, B. Descours, A. L. C. Valadão, N. Laguette, and M. Benkirane, “Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1,” Cell Reports, vol. 3, no. 4, pp. 1036–1043, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. C. H. Yam, T. K. Fung, and R. Y. C. Poon, “Cyclin A in cell cycle control and cancer,” Cellular and Molecular Life Sciences, vol. 59, no. 8, pp. 1317–1326, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. S. H. Woo, S.-K. Seo, S. An et al., “Implications of caspase-dependent proteolytic cleavage of cyclin A1 in DNA damage-induced cell death,” Biochemical and Biophysical Research Communications, vol. 453, no. 3, pp. 438–442, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Hirt Bartholomäus, Mathematical Modelling of Cell Cycle and Telomere Dynamics, University of Nottingham, 2013.
  35. Y. F. Ho, S. A. Karsani, W. K. Yong, and S. N. Abd Malek, “Induction of apoptosis and cell cycle blockade by helichrysetin in A549 human lung adenocarcinoma cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 857257, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Chen, M. S. Bhojani, A. C. Heaford et al., “Phosphorylated FADD induces NF-κB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12507–12512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. J. D. Gordan, P. Lal, V. R. Dondeti et al., “HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma,” Cancer Cell, vol. 14, no. 6, pp. 435–446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Yamada, H. Hidaka, N. Seki et al., “Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma,” Cancer Science, vol. 104, no. 3, pp. 304–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. G. K. Balendiran, R. Dabur, and D. Fraser, “The role of glutathione in cancer,” Cell Biochemistry and Function, vol. 22, no. 6, pp. 343–352, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Traverso, R. Ricciarelli, M. Nitti et al., “Role of glutathione in cancer progression and chemoresistance,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 972913, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-F. Hao, K.-M. Ren, J.-X. Bai et al., “Identification of potential biomarkers for clear cell renal cell carcinoma based on microRNA-mRNA pathway relationships,” Journal of Cancer Research and Therapeutics, vol. 10, pp. C167–C172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Perroud, J. Lee, N. Valkova et al., “Pathway analysis of kidney cancer using proteomics and metabolic profiling,” Molecular Cancer, vol. 5, article 64, 2006. View at Publisher · View at Google Scholar · View at Scopus